Factorial analysis optimization of memantine hydrochloride spectrofluorimetric quantitation via derivatization with o-phthalaldehyde in the absence of thiol
DOI:
https://doi.org/10.56511/JIPBS.2017.v4.i04.pp176-184Abstract
Memantine hydrochloride, low-to-moderate affinity noncompetitive N-methyl-D-aspartate receptor antagonist, is used in the treatment of patients with moderate to severe Alzheimer’s disease. Chemically, Memantine is an aliphatic tricyclic primary amine compound which lacks any UV or fluorescence properties. Previous studies have reported the spectrophotometric quantification of memantine after derivatization reactions with different reagents. In this paper, we reported the formation of a fluorescent product by reacting memantine hydrochloride and o-phthalaldehyde in the absence of a thiol. Experimental design methodologies were used in the optimization step. The variables under investigation were: pH; the ratio between memantine hydrochloride: o-phthalaldehyde and heating time. The results of statistical analysis of two sequential full factorial design were used for quantification of memantine hydrochloride at optimized reaction condition. Optimal conditions for derivatization were: aqueous NaOH, pH 12.2, memantine hydrochloride:o-phthalaldehyde ratio of 1:5, and heating at 70oC for 45 min. A new eco-friendly spectrofluorimetric derivatization procedure has been developed and validated for analysis of memantine hydrochloride. The linear range was 0.25–10 µg/mL with a quantification limit of 1.97 µg/mL, detection limit of 0.65 µg/mLwith maximum fluorescence intensity development at λex 350 nm and λem 427 nm
Keywords:
Memantine, o-phthalaldehyde, Spectrofluorimetry, Factorial designDownloads
References
Fiorino A, Frigo G and Cucchetti E: Liquid chromatographic analysis of amino and imino acids in protein hydrolysates by post-column derivatization with o-phthalaldehyde and 3-mercaptoproptonic acid. Journal of Chromatography 1989; 416: 83-92.
Rao N, Maurya PK, Shinde DD and Khalid S: Precolumnderivatization followed by liquid chromatographic separation and determination of tramiprosate in rat plasma by fluorescence detector: Application to pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis 2011; 55: 282 – 287.
Srikanth R, Reddy DR and Venkatesan CS: Development and validation of rp-HPLC pre-column derivatisation for the trace level determination of tert. Butylamine in tigecycline drug substance. International Journal of Pharmaceutical and Biological Science 2013; 4 (2): 522-531.
Yan CC and Huxtable RJ: Fluorimetric determination of monobromobimane and o-phthalaldehyde adducts of y-glutamylcysteine and glutathione: application to assay of y-glutamylcysteinylsynthetase MTH found Average % % (μg/mL) ± SD* % Recovery RSD Error 4.95 99.00 ± 0.53 0.53 0.50 4.90 98.00 ± 0.65 0.66 1.30 10.06 100.60 ± 0.75 0.75 0.20 9.87 98.70 ± 0.38 0.38 0.93 % Recovery % RSD 102.50 0.95 99.60 0.81 99.50 0.12 activity and glutathione concentration in liver. Journal of Chromatography B1995; 672: 217-224.
Herbert P, Barros P, Ratola N and Alves A: HPLC determination of amino acids in musts and port wine using OPA/FMOC derivatives.Journal ofFoodScience2000; 65: 1130-1133.
Frattinia V and Lionettib C: Histamine and histidine determination in tuna fish samples using high-performance liquid chromatography derivatization with o-phthalaldehyde and fluorescence detection or UV detection of ‘‘free’’ species. Journal of Chromatography A1998; 809: 241 – 245.
Musson DG, Maglietto SM and Bayne WF: determination of the antibiotic fludalanine in plasma and urine by high-performance liquid chromatography using a packed-bed, post-column reactor with ophthalaldehyde and 2-mercaptoethanol.Journal of Chromatography 1985; 338: 357-367.
Navas MJ and Jimenez AM: Analytical methods to determine antiinfluenza drugs. Critical Reviews in Analytical Chemistry 2011; 41: 81 – 97.
Al Deeb SK, Hamdan II and Al Najjar S M: Analytical methods to determine anti-influenza drugs. Talanta 2004; 64: 695 – 702.
Dousa M, Pivonkova V and Sykora D: Optimization of ophtaldialdehyde/2-mercaptoethanolpostcolumn reaction for the hydrophilic interaction liquid chromatography determination of memantine utilizing a silica hydride stationary phase. Journal of Separation Science 2016; 39: 3145 – 3155.
Michail M, Daabees H, Beltagy Y, Abdelkhalek M and Khamis M: Spectrophotometric and spectrofluorimetric determination of memantine hydrochloride in bulk and pharmaceutical preparations. International Journal of Pharmacy and Pharmaceutical science 2011; 3: 180-185.
Zhao M and Bada JL: Determination of α -dialkylamino acids and their enantiomers ingeological samples by high-performance liquid chromatography after derivatizationwith a chiral adduct of ophthalaldehyde. Journal of Chromatography A 1995; 690: 55-63.
Desai DM and Gal J: Enantiospecific drug analysis via the orthophthalaldehyde/homochiral thiol derivatization method. Journal of Chromatography 1993; 629: 215-228.
DoMinh T, Johnson AL, Jones J E and Senise PP: Reactions of phthalaldehyde with ammonia and amines. Journal of Organic Chemistry 1977;42:4217-4221.
Forras KG, Leitner A, Akasaka K and Lindner W: Comparative study on the use of orthophthalaldehyde, naphthalene-2,3-dicarboxaldehyde and anthracene-2,3-dicarboxaldehyde reagents for α -amino acids followed by the enantiomer separation of the formed isoindolin-1-one derivatives using quinine-type chiral stationary phases. Journal ofChromatography A 2005; 1083: 80 – 88.
Alvarez-Coque MCG, Hernández MJM, Camañas RMV and Fernández CM: Spectrophotometric determination of cysteine with o-phthalaldehyde in the absence of thiol. analytical letters 1988; 21(9): 1545-1559.
Maliha B, Hussain I, Tariq MI and Siddiqui HL: Mechanistic studies on the reaction of o-phthalaldehyde (OPTA) with urea and its N-alkyvaryl derivatives. Journal of The Chemical Society of Pakistan 2009; 31: 829837.
Jung D, Biggs H, Erikson J and Ledyard PU: New colorimetric reaction for end-point, continuous-flow, and kinetic measurement of urea. Clinical Chemistry 1975; 21: 1136-1140.
Schneider E, Fischer PA, Clemens R, Balzereit F, Funfgeld EW, Haase HJ: Effects of oral memantine administration on parkinson symptoms. Results of a placebo-controlled multicenter study. Deutsche MedizinischeWochenschrift 1984; 109: 987-990.
Hanney M, Prasher V, Williams N, Jones EL, Aarsland D, Corbett A, Lawrence D, Yu Land Tyrer S: Memantine for dementia in adults older than 40 years with Down’s syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet 2012; 379: 528 – 536.
Yu¨cel YH, Gupta N, Zhang Q, Mizisin AP, Kalichman MW and Weinreb RN: Memantine protects neurons from shrinkage in the lateral geniculate nucleusin experimental glaucoma. Archives of Ophthalmology 2006; 124: 217-225.
Winblad B, Jones RW, Wirth Y, Stofler A and Mobius HJ: Memantine in moderate to severe alzheimer’s disease: a meta -analysis of randomised clinical trials. Dementia and. Geriatric Cognitive Disorders 2007; 24: 20 – 27.
Suckow RF, Zhang MF, Collins ED, Fischman MW and Cooper TB: Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. Journal of Chromatography B 1999; 729: 217 – 224.
Zarghi A, Shafaati A, Foroutan SM, Khoddam A and Madadian B: Sensitive and rapid HPLC method for determination of memantine in human plasma using opaderivatization and fluorescence detection: application to pharmacokinetic studies. ScietiaPharmaceutica 2010; 78: 847 – 856.
Puente B, Hernandez E, Perez S, Pablo L, Prieto E, Garcia MA and Bregante MA: Determination of memantine in plasma and vitreous humour by HPLC with precolumnderivatization and fluorescence detection. Journal of Chromatographic Science 2011; 49: 745-752.
Jing S-J, Li Q-L and Jiang Y: A new simultaneous derivatization and microextration method for the determination of memantine hydrochloride in human plasma. Journal of Chromatography B 2016; 1008: 26-31.
Leis HJ and Fauler G: Quantitative analysis of memantine in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry. Journal of Mass Spectrometry 2002; 37: 477 – 480.
Kornhuber J, Kennepohl EM, Bleich S, Wiltfang J, Krau T, Reulbach U, Meineke I: Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach. Clinical Pharmacokinetic 2007; 46: 599 – 612.
César IC, Byrro RMD, Silva FFS, Mundim IM, Teixeira LS, Crunivel de Abreu F and Pianetti GA: Bioequivalence study of two oral formulations of memantine tablets in healthy brazilian volunteers after a single dose administration. Journal of Bioequivalence and Availability 2012; 4: 1417.
Bhateria M, Ramakrishna R, Pakala DB and Bhatta RS: Development of an LC – MS/MS method for simultaneous determination of memantine and donepezil in rat plasma and its application to pharmacokinetic study.Journal Chromatography B 2015; 1001: 131-139.
Yeh HH, Yang YH and Chen SH: Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application. Electrophoresis 2010; 31: 19031911.
Jagathi V, Anupama B, Praven PS and Rao GD: Spectrophotometric determination of memantine in bulk and pharmaceutical formulations. International journal of Current Pharmaceutical Research 2010; 2: 17-18.
Munday R: Toxicity of thiols and disulphides: involvement of free-radical species.Free Radical Biology and Medicine 1989; 7(6): 659-673.
Omara HA and Younis HM: Spectrophotometric determination of alzheimer’s drug, memantine hydrochloride in biological samples using ninhydrin and ferric chloride. IOSR Journal of Applied Chemistry 2017; 10: 52-59.
Leitao JMM and Esteves da Silva JCG: Factorial analysis optimization of a diltiazem kinetic spectrophotometric quantification method. AnalyticaChimicaActa 2008; 609: 1 – 12.
Abdel-Aziz O, Ayad MF and Tadros MM: Compatible validated spectrofluorimetric and spectrophotometric methods for determination of vildagliptin and saxagliptin by factorial design experiments. SpectrochimicaActa Part A: Molecular and Biomolecular Spectroscopy 2015; 140: 229 – 240.
Minitab 18 Statistical Software (2017). [Computer software]. State College, PA: Minitab, Inc. (www.minitab.com).
Duh TH, Wu HL, Pan CW and Kou HS: Fluorimetric liquid chromatographic analysis of amantadine in urine and pharmaceutical formulation. Journal of Chromatography A 2005; 1088:175 – 181.
Rani AP, Bhawani S, Nagalakshmi C and Sekaran CB: Determination of memantine hydrochloride by spectrophotome try using anionic dyes, bromothymol blue and solochrome black T, in bulk and tablet dosage forms. Chemical Science Journal 2012; 60: 1 - 9.
Omara HA and Amin AS: Extractive-spectrophotometric methods for determination of alzheimer’s drug in pharmaceutical fo rmulations and in biological samples using sulphonphthalein acid dyes. Canadian Chemical Transactions 2016; 4: 17-31.
Kiendrebeogo M, Choisnard L, Lamien CE, Meda A, Wouessidjewe D andNacoulmaOG: Experimental design optimization for screening relevant free phenolic acids from various preparations used in Burkina Faso folk medicine. African Journal of Traditional, Complementary and Alternative Medicines 2006; 3: 115-128.
ICH-Q2B Validation of Analytical Procedures: Methodology International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland 1996.
Published
How to Cite
Issue
Section
Copyright (c) 2017 Mervat Hamed El-Hamamsy

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at